CA2867481A1 - Tuberculosis biomarkers and uses thereof - Google Patents

Info

Publication number

CA2867481A1

CA2867481A1 CA2867481A CA2867481A CA2867481A1 CA 2867481 A1 CA2867481 A1 CA 2867481A1 CA 2867481 A CA2867481 A CA 2867481A CA 2867481 A CA2867481 A CA 2867481A CA 2867481 A1 CA2867481 A1 CA 2867481A1

Authority

CA

Canada

Prior art keywords

biomarker

individual

biomarkers

biological sample

treatment

Prior art date

2012-04-13

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 239000000090 biomarker Substances 0.000 title claims abstract description 645
• 201000008827 tuberculosis Diseases 0.000 title claims abstract description 99
• 238000000034 method Methods 0.000 claims abstract description 291
• 238000011282 treatment Methods 0.000 claims abstract description 170
• 239000012472 biological sample Substances 0.000 claims abstract description 102
• 230000004044 response Effects 0.000 claims abstract description 70
• 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 65
• 238000003745 diagnosis Methods 0.000 claims abstract description 44
• 108090000623 proteins and genes Proteins 0.000 claims description 226
• 102000004169 proteins and genes Human genes 0.000 claims description 212
• 108091023037 Aptamer Proteins 0.000 claims description 167
• 239000000523 sample Substances 0.000 claims description 139
• -1 antibodies Proteins 0.000 claims description 119
• 230000014509 gene expression Effects 0.000 claims description 116
• 238000003556 assay Methods 0.000 claims description 86
• 208000015181 infectious disease Diseases 0.000 claims description 61
• 238000004458 analytical method Methods 0.000 claims description 57
• 238000011156 evaluation Methods 0.000 claims description 55
• 210000002966 serum Anatomy 0.000 claims description 36
• 102100037529 Coagulation factor V Human genes 0.000 claims description 35
• 108010014172 Factor V Proteins 0.000 claims description 35
• 102000003815 Interleukin-11 Human genes 0.000 claims description 34
• 108090000177 Interleukin-11 Proteins 0.000 claims description 34
• 102100031758 Extracellular matrix protein 1 Human genes 0.000 claims description 33
• 206010036790 Productive cough Diseases 0.000 claims description 33
• 230000007420 reactivation Effects 0.000 claims description 33
• 210000003802 sputum Anatomy 0.000 claims description 33
• 208000024794 sputum Diseases 0.000 claims description 33
• 102100031300 Proteasome activator complex subunit 1 Human genes 0.000 claims description 32
• 102100038365 Xaa-Pro aminopeptidase 1 Human genes 0.000 claims description 32
• 101000866526 Homo sapiens Extracellular matrix protein 1 Proteins 0.000 claims description 31
• 101000983161 Homo sapiens Phospholipase A2, membrane associated Proteins 0.000 claims description 30
• 102100026831 Phospholipase A2, membrane associated Human genes 0.000 claims description 30
• 238000004393 prognosis Methods 0.000 claims description 30
• 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 claims description 29
• 108010031372 Tissue Inhibitor of Metalloproteinase-2 Proteins 0.000 claims description 28
• 102000044445 Galectin-8 Human genes 0.000 claims description 27
• 101000608769 Homo sapiens Galectin-8 Proteins 0.000 claims description 27
• 108010002586 Interleukin-7 Proteins 0.000 claims description 27
• 102100029219 Thrombospondin-4 Human genes 0.000 claims description 26
• 101710163595 Chaperone protein DnaK Proteins 0.000 claims description 25
• 101710178376 Heat shock 70 kDa protein Proteins 0.000 claims description 25
• 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 claims description 25
• 108090000935 Antithrombin III Proteins 0.000 claims description 24
• 102000004411 Antithrombin III Human genes 0.000 claims description 24
• 102000004375 Insulin-like growth factor-binding protein 1 Human genes 0.000 claims description 24
• 108090000957 Insulin-like growth factor-binding protein 1 Proteins 0.000 claims description 24
• 229960005348 antithrombin iii Drugs 0.000 claims description 24
• 102100036284 Hepcidin Human genes 0.000 claims description 22
• 101001021253 Homo sapiens Hepcidin Proteins 0.000 claims description 22
• 238000004590 computer program Methods 0.000 claims description 21
• 210000004369 blood Anatomy 0.000 claims description 16
• 239000008280 blood Substances 0.000 claims description 16
• 230000002380 cytological effect Effects 0.000 claims description 15
• 238000003018 immunoassay Methods 0.000 claims description 15
• 239000012530 fluid Substances 0.000 claims description 13
• 108020004999 messenger RNA Proteins 0.000 claims description 12
• 210000002700 urine Anatomy 0.000 claims description 11
• 210000004072 lung Anatomy 0.000 claims description 10
• 210000002381 plasma Anatomy 0.000 claims description 9
• 101710190759 Serum amyloid A protein Proteins 0.000 claims description 7
• 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 4
• 239000002853 nucleic acid probe Substances 0.000 claims description 4
• 230000000306 recurrent effect Effects 0.000 claims description 2
• 238000000099 in vitro assay Methods 0.000 claims 6
• 102100021834 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 claims 4
• 102100031051 Cysteine and glycine-rich protein 1 Human genes 0.000 claims 4
• 101100208245 Danio rerio thbs4b gene Proteins 0.000 claims 4
• 101000705756 Homo sapiens Proteasome activator complex subunit 1 Proteins 0.000 claims 4
• 101000666502 Homo sapiens Xaa-Pro aminopeptidase 1 Proteins 0.000 claims 4
• 101710089435 Lipopolysaccharide-binding protein Proteins 0.000 claims 4
• 101100078144 Mus musculus Msrb1 gene Proteins 0.000 claims 4
• 241001334141 Rugopharynx alpha Species 0.000 claims 4
• 102100032277 Serum amyloid A-1 protein Human genes 0.000 claims 4
• 101150053966 THBS4 gene Proteins 0.000 claims 4
• 108091006374 cAMP receptor proteins Proteins 0.000 claims 4
• 238000001514 detection method Methods 0.000 abstract description 64
• 235000018102 proteins Nutrition 0.000 description 195
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 159
• 201000010099 disease Diseases 0.000 description 155
• 210000001519 tissue Anatomy 0.000 description 58
• 238000012360 testing method Methods 0.000 description 52
• 230000000875 corresponding effect Effects 0.000 description 48
• 210000004027 cell Anatomy 0.000 description 47
• 102000054727 Serum Amyloid A Human genes 0.000 description 46
• 108700028909 Serum Amyloid A Proteins 0.000 description 43
• 230000008569 process Effects 0.000 description 43
• 239000007787 solid Substances 0.000 description 42
• 150000007523 nucleic acids Chemical class 0.000 description 40
• 102000039446 nucleic acids Human genes 0.000 description 39
• 108020004707 nucleic acids Proteins 0.000 description 39
• 230000035945 sensitivity Effects 0.000 description 32
• 230000001965 increasing effect Effects 0.000 description 29
• 238000005259 measurement Methods 0.000 description 29
• 108010074051 C-Reactive Protein Proteins 0.000 description 28
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
• 101710103872 Proteasome activator complex subunit 1 Proteins 0.000 description 28
• 101710081951 Xaa-Pro aminopeptidase 1 Proteins 0.000 description 28
• 230000000694 effects Effects 0.000 description 28
• 238000002560 therapeutic procedure Methods 0.000 description 28
• 102100032752 C-reactive protein Human genes 0.000 description 27
• 230000027455 binding Effects 0.000 description 27
• 102100025351 C-type mannose receptor 2 Human genes 0.000 description 25
• 101000576898 Homo sapiens C-type mannose receptor 2 Proteins 0.000 description 25
• 239000003550 marker Substances 0.000 description 25
• 102000052508 Lipopolysaccharide-binding protein Human genes 0.000 description 23
• 108010053632 Lipopolysaccharide-binding protein Proteins 0.000 description 23
• 239000012491 analyte Substances 0.000 description 22
• 230000006870 function Effects 0.000 description 22
• 239000000463 material Substances 0.000 description 22
• 108010060815 thrombospondin 4 Proteins 0.000 description 22
• 239000003814 drug Substances 0.000 description 21
• 238000012545 processing Methods 0.000 description 21
• 239000000203 mixture Substances 0.000 description 20
• 238000012549 training Methods 0.000 description 20
• 238000003384 imaging method Methods 0.000 description 19
• 238000012163 sequencing technique Methods 0.000 description 18
• 230000008859 change Effects 0.000 description 17
• 229940079593 drug Drugs 0.000 description 17
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 16
• 230000003247 decreasing effect Effects 0.000 description 16
• 239000003446 ligand Substances 0.000 description 16
• 239000000243 solution Substances 0.000 description 16
• 125000003729 nucleotide group Chemical group 0.000 description 15
• 238000010186 staining Methods 0.000 description 15
• 102000004506 Blood Proteins Human genes 0.000 description 14
• 108010017384 Blood Proteins Proteins 0.000 description 14
• 238000005516 engineering process Methods 0.000 description 14
• 102000004190 Enzymes Human genes 0.000 description 13
• 108090000790 Enzymes Proteins 0.000 description 13
• 238000013459 approach Methods 0.000 description 13
• 239000003795 chemical substances by application Substances 0.000 description 13
• 229940088598 enzyme Drugs 0.000 description 13
• 229940012952 fibrinogen Drugs 0.000 description 13
• 230000001976 improved effect Effects 0.000 description 13
• 238000004949 mass spectrometry Methods 0.000 description 13
• 108090000765 processed proteins & peptides Proteins 0.000 description 13
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
• 229920001817 Agar Polymers 0.000 description 12
• 108010049003 Fibrinogen Proteins 0.000 description 12
• 102000008946 Fibrinogen Human genes 0.000 description 12
• 108091034117 Oligonucleotide Proteins 0.000 description 12
• 239000008272 agar Substances 0.000 description 12
• 238000009396 hybridization Methods 0.000 description 12
• 239000002609 medium Substances 0.000 description 12
• 238000012544 monitoring process Methods 0.000 description 12
• 102000005754 Cytokine Receptor gp130 Human genes 0.000 description 11
• 108010006197 Cytokine Receptor gp130 Proteins 0.000 description 11
• 108020004414 DNA Proteins 0.000 description 11
• 150000001413 amino acids Chemical group 0.000 description 11
• 238000006243 chemical reaction Methods 0.000 description 11
• 238000005345 coagulation Methods 0.000 description 11
• 230000015271 coagulation Effects 0.000 description 11
• 230000001186 cumulative effect Effects 0.000 description 11
• 238000011161 development Methods 0.000 description 11
• 230000018109 developmental process Effects 0.000 description 11
• 238000009826 distribution Methods 0.000 description 11
• 239000011159 matrix material Substances 0.000 description 11
• 238000003860 storage Methods 0.000 description 11
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 10
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 10
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 10
• 102000013566 Plasminogen Human genes 0.000 description 10
• 108010051456 Plasminogen Proteins 0.000 description 10
• 239000000872 buffer Substances 0.000 description 10
• 210000002744 extracellular matrix Anatomy 0.000 description 10
• 239000007788 liquid Substances 0.000 description 10
• 239000002679 microRNA Substances 0.000 description 10
• 230000004048 modification Effects 0.000 description 10
• 238000012986 modification Methods 0.000 description 10
• 238000003199 nucleic acid amplification method Methods 0.000 description 10
• 102000004196 processed proteins & peptides Human genes 0.000 description 10
• 239000000047 product Substances 0.000 description 10
• 239000000126 substance Substances 0.000 description 10
• 208000024891 symptom Diseases 0.000 description 10
• 108010076365 Adiponectin Proteins 0.000 description 9
• 102100031786 Adiponectin Human genes 0.000 description 9
• 230000007423 decrease Effects 0.000 description 9
• 238000005315 distribution function Methods 0.000 description 9
• 239000000975 dye Substances 0.000 description 9
• 239000000834 fixative Substances 0.000 description 9
• 108091070501 miRNA Proteins 0.000 description 9
• 239000002245 particle Substances 0.000 description 9
• 238000002360 preparation method Methods 0.000 description 9
• 102100022641 Coagulation factor IX Human genes 0.000 description 8
• 108010076282 Factor IX Proteins 0.000 description 8
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 8
• 102100027998 Macrophage metalloelastase Human genes 0.000 description 8
• 108010076501 Matrix Metalloproteinase 12 Proteins 0.000 description 8
• 102100040247 Tumor necrosis factor Human genes 0.000 description 8
• 230000003321 amplification Effects 0.000 description 8
• 102000052586 bactericidal permeability increasing protein Human genes 0.000 description 8
• 108010032816 bactericidal permeability increasing protein Proteins 0.000 description 8
• 229940105774 coagulation factor ix Drugs 0.000 description 8
• 239000011521 glass Substances 0.000 description 8
• 238000010438 heat treatment Methods 0.000 description 8
• 238000007477 logistic regression Methods 0.000 description 8
• 230000037361 pathway Effects 0.000 description 8
• 102000005962 receptors Human genes 0.000 description 8
• 108020003175 receptors Proteins 0.000 description 8
• 230000001105 regulatory effect Effects 0.000 description 8
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
• 102100024456 Cyclin-dependent kinase 8 Human genes 0.000 description 7
• 102100030074 Dickkopf-related protein 1 Human genes 0.000 description 7
• 102100037362 Fibronectin Human genes 0.000 description 7
• 108010067306 Fibronectins Proteins 0.000 description 7
• 102100036000 G-protein coupled receptor-associated sorting protein 2 Human genes 0.000 description 7
• 101000980937 Homo sapiens Cyclin-dependent kinase 8 Proteins 0.000 description 7
• 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 7
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
• 102000035195 Peptidases Human genes 0.000 description 7
• 108091005804 Peptidases Proteins 0.000 description 7
• 102100024078 Plasma serine protease inhibitor Human genes 0.000 description 7
• 101710183733 Plasma serine protease inhibitor Proteins 0.000 description 7
• 108010045517 Serum Amyloid P-Component Proteins 0.000 description 7
• 102100036202 Serum amyloid P-component Human genes 0.000 description 7
• 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 description 7
• 230000000845 anti-microbial effect Effects 0.000 description 7
• 230000008901 benefit Effects 0.000 description 7
• 230000002146 bilateral effect Effects 0.000 description 7
• 230000000295 complement effect Effects 0.000 description 7
• 230000001419 dependent effect Effects 0.000 description 7
• 239000000499 gel Substances 0.000 description 7
• 230000035876 healing Effects 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 238000002493 microarray Methods 0.000 description 7
• 244000052769 pathogen Species 0.000 description 7
• 230000007170 pathology Effects 0.000 description 7
• 239000008188 pellet Substances 0.000 description 7
• 229920001184 polypeptide Polymers 0.000 description 7
• 208000008128 pulmonary tuberculosis Diseases 0.000 description 7
• 238000007637 random forest analysis Methods 0.000 description 7
• JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 7
• 230000007838 tissue remodeling Effects 0.000 description 7
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
• 239000008096 xylene Substances 0.000 description 7
• LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 description 6
• 108010088751 Albumins Proteins 0.000 description 6
• 102000009027 Albumins Human genes 0.000 description 6
• 241000193830 Bacillus <bacterium> Species 0.000 description 6
• 102100025975 Cathepsin G Human genes 0.000 description 6
• 108090000617 Cathepsin G Proteins 0.000 description 6
• 102100031667 Cell adhesion molecule-related/down-regulated by oncogenes Human genes 0.000 description 6
• 102000002428 Cyclin C Human genes 0.000 description 6
• 108010068155 Cyclin C Proteins 0.000 description 6
• SXVPOSFURRDKBO-UHFFFAOYSA-N Cyclododecanone Chemical compound O=C1CCCCCCCCCCC1 SXVPOSFURRDKBO-UHFFFAOYSA-N 0.000 description 6
• 101710099518 Dickkopf-related protein 1 Proteins 0.000 description 6
• 102000014702 Haptoglobin Human genes 0.000 description 6
• 108050005077 Haptoglobin Proteins 0.000 description 6
• 101000777781 Homo sapiens Cell adhesion molecule-related/down-regulated by oncogenes Proteins 0.000 description 6
• 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 description 6
• 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 description 6
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 6
• 101000839464 Leishmania braziliensis Heat shock 70 kDa protein Proteins 0.000 description 6
• 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 description 6
• 102100036154 Platelet basic protein Human genes 0.000 description 6
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 6
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 6
• 102100029529 Thrombospondin-2 Human genes 0.000 description 6
• 230000002159 abnormal effect Effects 0.000 description 6
• 230000004913 activation Effects 0.000 description 6
• 208000036981 active tuberculosis Diseases 0.000 description 6
• 229960002685 biotin Drugs 0.000 description 6
• 235000020958 biotin Nutrition 0.000 description 6
• 239000011616 biotin Substances 0.000 description 6
• 230000000903 blocking effect Effects 0.000 description 6
• 238000004422 calculation algorithm Methods 0.000 description 6
• 238000004364 calculation method Methods 0.000 description 6
• 238000004891 communication Methods 0.000 description 6
• 239000002872 contrast media Substances 0.000 description 6
• 238000002405 diagnostic procedure Methods 0.000 description 6
• 239000012634 fragment Substances 0.000 description 6
• 230000028993 immune response Effects 0.000 description 6
• 230000003993 interaction Effects 0.000 description 6
• 239000012528 membrane Substances 0.000 description 6
• 230000002906 microbiologic effect Effects 0.000 description 6
• 229920000642 polymer Polymers 0.000 description 6
• 238000000611 regression analysis Methods 0.000 description 6
• 229960001225 rifampicin Drugs 0.000 description 6
• 238000000926 separation method Methods 0.000 description 6
• 108010060887 thrombospondin 2 Proteins 0.000 description 6
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 5
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 5
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 5
• 102100034594 Angiopoietin-1 Human genes 0.000 description 5
• 108010048154 Angiopoietin-1 Proteins 0.000 description 5
• 102100030009 Azurocidin Human genes 0.000 description 5
• 101710154607 Azurocidin Proteins 0.000 description 5
• 108010072135 Cell Adhesion Molecule-1 Proteins 0.000 description 5
• 102100024649 Cell adhesion molecule 1 Human genes 0.000 description 5
• 239000003154 D dimer Substances 0.000 description 5
• 238000002965 ELISA Methods 0.000 description 5
• 206010016654 Fibrosis Diseases 0.000 description 5
• 101710142639 G-protein coupled receptor-associated sorting protein 2 Proteins 0.000 description 5
• 102100028896 Heterogeneous nuclear ribonucleoprotein Q Human genes 0.000 description 5
• 101000722210 Homo sapiens ATP-dependent DNA helicase DDX11 Proteins 0.000 description 5
• 101000929698 Homo sapiens Aspartate aminotransferase, cytoplasmic Proteins 0.000 description 5
• 101001017855 Homo sapiens Leucine-rich repeats and immunoglobulin-like domains protein 3 Proteins 0.000 description 5
• 101001112222 Homo sapiens Neural cell adhesion molecule L1-like protein Proteins 0.000 description 5
• 101000904228 Homo sapiens Vesicle transport protein GOT1A Proteins 0.000 description 5
• 101000904204 Homo sapiens Vesicle transport protein GOT1B Proteins 0.000 description 5
• 102100023012 Kallistatin Human genes 0.000 description 5
• 102100033284 Leucine-rich repeats and immunoglobulin-like domains protein 3 Human genes 0.000 description 5
• 108010051335 Lipocalin-2 Proteins 0.000 description 5
• 102000013519 Lipocalin-2 Human genes 0.000 description 5
• 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 5
• 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 5
• 102100023616 Neural cell adhesion molecule L1-like protein Human genes 0.000 description 5
• 101150056950 Ntrk2 gene Proteins 0.000 description 5
• 102000004211 Platelet factor 4 Human genes 0.000 description 5
• 108090000778 Platelet factor 4 Proteins 0.000 description 5
• 101150005863 SYNCRIP gene Proteins 0.000 description 5
• 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 5
• 102400000015 Vasoactive intestinal peptide Human genes 0.000 description 5
• 102100024010 Vesicle transport protein GOT1A Human genes 0.000 description 5
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 5
• 238000002820 assay format Methods 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 230000015556 catabolic process Effects 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 230000024203 complement activation Effects 0.000 description 5
• 239000000539 dimer Substances 0.000 description 5
• 238000001035 drying Methods 0.000 description 5
• 230000002255 enzymatic effect Effects 0.000 description 5
• 108010052295 fibrin fragment D Proteins 0.000 description 5
• 230000004761 fibrosis Effects 0.000 description 5
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 5
• 239000007850 fluorescent dye Substances 0.000 description 5
• 230000002068 genetic effect Effects 0.000 description 5
• 238000000338 in vitro Methods 0.000 description 5
• 230000028709 inflammatory response Effects 0.000 description 5
• VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 5
• 150000002500 ions Chemical class 0.000 description 5
• 108010050180 kallistatin Proteins 0.000 description 5
• 238000002372 labelling Methods 0.000 description 5
• 230000015654 memory Effects 0.000 description 5
• 239000002773 nucleotide Substances 0.000 description 5
• 230000003287 optical effect Effects 0.000 description 5
• 210000000056 organ Anatomy 0.000 description 5
• 235000019833 protease Nutrition 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 229920005989 resin Polymers 0.000 description 5
• 239000011347 resin Substances 0.000 description 5
• 239000003001 serine protease inhibitor Substances 0.000 description 5
• 108010035597 sphingosine kinase Proteins 0.000 description 5
• 239000000758 substrate Substances 0.000 description 5
• 239000002753 trypsin inhibitor Substances 0.000 description 5
• 230000003827 upregulation Effects 0.000 description 5
• 102100026802 72 kDa type IV collagenase Human genes 0.000 description 4
• 101710151806 72 kDa type IV collagenase Proteins 0.000 description 4
• 102100036774 Afamin Human genes 0.000 description 4
• 101710149366 Afamin Proteins 0.000 description 4
• 102100025440 BMP-binding endothelial regulator protein Human genes 0.000 description 4
• 102100031006 Beta-Ala-His dipeptidase Human genes 0.000 description 4
• 102100028728 Bone morphogenetic protein 1 Human genes 0.000 description 4
• 108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 4
• 108050006947 CXC Chemokine Proteins 0.000 description 4
• 102000019388 CXC chemokine Human genes 0.000 description 4
• 102100029761 Cadherin-5 Human genes 0.000 description 4
• 102100036369 Carbonic anhydrase 6 Human genes 0.000 description 4
• 102100027995 Collagenase 3 Human genes 0.000 description 4
• 101100457345 Danio rerio mapk14a gene Proteins 0.000 description 4
• 101100457347 Danio rerio mapk14b gene Proteins 0.000 description 4
• 102100037985 Dickkopf-related protein 3 Human genes 0.000 description 4
• 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 4
• 108010067770 Endopeptidase K Proteins 0.000 description 4
• 102100028044 Fetuin-B Human genes 0.000 description 4
• 102000004858 Growth differentiation factor-9 Human genes 0.000 description 4
• 108090001086 Growth differentiation factor-9 Proteins 0.000 description 4
• 108090000481 Heparin Cofactor II Proteins 0.000 description 4
• 102100030500 Heparin cofactor 2 Human genes 0.000 description 4
• 101000934632 Homo sapiens BMP-binding endothelial regulator protein Proteins 0.000 description 4
• 101000919694 Homo sapiens Beta-Ala-His dipeptidase Proteins 0.000 description 4
• 101000951342 Homo sapiens Dickkopf-related protein 3 Proteins 0.000 description 4
• 101001060279 Homo sapiens Fetuin-B Proteins 0.000 description 4
• 101000760817 Homo sapiens Macrophage-capping protein Proteins 0.000 description 4
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 4
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 4
• 102100029228 Insulin-like growth factor-binding protein 7 Human genes 0.000 description 4
• 102100039457 Inter-alpha-trypsin inhibitor heavy chain H4 Human genes 0.000 description 4
• 101710083924 Inter-alpha-trypsin inhibitor heavy chain H4 Proteins 0.000 description 4
• 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 4
• 101710152369 Interleukin-6 receptor subunit beta Proteins 0.000 description 4
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
• 108010063045 Lactoferrin Proteins 0.000 description 4
• 102000010445 Lactoferrin Human genes 0.000 description 4
• 208000019693 Lung disease Diseases 0.000 description 4
• 108700012928 MAPK14 Proteins 0.000 description 4
• 101150104297 MASP1 gene Proteins 0.000 description 4
• 102100024573 Macrophage-capping protein Human genes 0.000 description 4
• 101150003941 Mapk14 gene Proteins 0.000 description 4
• 108010076503 Matrix Metalloproteinase 13 Proteins 0.000 description 4
• 102000054819 Mitogen-activated protein kinase 14 Human genes 0.000 description 4
• 102000016943 Muramidase Human genes 0.000 description 4
• 108010014251 Muramidase Proteins 0.000 description 4
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
• 101150117329 NTRK3 gene Proteins 0.000 description 4
• 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 description 4
• 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 description 4
• 102100030411 Neutrophil collagenase Human genes 0.000 description 4
• 102100032393 Peptidoglycan recognition protein 1 Human genes 0.000 description 4
• 101710113134 Peptidoglycan recognition protein 1 Proteins 0.000 description 4
• 102100026918 Phospholipase A2 Human genes 0.000 description 4
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 4
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 4
• 239000002202 Polyethylene glycol Substances 0.000 description 4
• 102000012479 Serine Proteases Human genes 0.000 description 4
• 108010022999 Serine Proteases Proteins 0.000 description 4
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
• 102100039024 Sphingosine kinase 1 Human genes 0.000 description 4
• 206010070863 Toxicity to various agents Diseases 0.000 description 4
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 4
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 4
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 4
• 230000008238 biochemical pathway Effects 0.000 description 4
• 210000001124 body fluid Anatomy 0.000 description 4
• 239000010839 body fluid Substances 0.000 description 4
• 239000008366 buffered solution Substances 0.000 description 4
• 108010018828 cadherin 5 Proteins 0.000 description 4
• 108010019521 carbonic anhydrase VI Proteins 0.000 description 4
• 210000000038 chest Anatomy 0.000 description 4
• 230000002596 correlated effect Effects 0.000 description 4
• 238000002790 cross-validation Methods 0.000 description 4
• 238000007405 data analysis Methods 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 238000003795 desorption Methods 0.000 description 4
• 239000003599 detergent Substances 0.000 description 4
• 238000010790 dilution Methods 0.000 description 4
• 239000012895 dilution Substances 0.000 description 4
• 208000035475 disorder Diseases 0.000 description 4
• 238000010494 dissociation reaction Methods 0.000 description 4
• 230000005593 dissociations Effects 0.000 description 4
• 230000003828 downregulation Effects 0.000 description 4
• AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 4
• UHBYWPGGCSDKFX-VKHMYHEASA-N gamma-carboxy-L-glutamic acid Chemical compound OC(=O)[C@@H](N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-VKHMYHEASA-N 0.000 description 4
• 230000013595 glycosylation Effects 0.000 description 4
• 238000006206 glycosylation reaction Methods 0.000 description 4
• 239000012216 imaging agent Substances 0.000 description 4
• 238000011503 in vivo imaging Methods 0.000 description 4
• 239000003112 inhibitor Substances 0.000 description 4
• 230000015788 innate immune response Effects 0.000 description 4
• 108010008598 insulin-like growth factor binding protein-related protein 1 Proteins 0.000 description 4
• QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 4
• CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 4
• 229940078795 lactoferrin Drugs 0.000 description 4
• 235000021242 lactoferrin Nutrition 0.000 description 4
• 230000003902 lesion Effects 0.000 description 4
• 229960000274 lysozyme Drugs 0.000 description 4
• 239000004325 lysozyme Substances 0.000 description 4
• 235000010335 lysozyme Nutrition 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• 230000000877 morphologic effect Effects 0.000 description 4
• 210000000963 osteoblast Anatomy 0.000 description 4
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 4
• 230000035699 permeability Effects 0.000 description 4
• 229920001223 polyethylene glycol Polymers 0.000 description 4
• 230000005180 public health Effects 0.000 description 4
• 239000013049 sediment Substances 0.000 description 4
• 150000003384 small molecules Chemical class 0.000 description 4
• 238000000638 solvent extraction Methods 0.000 description 4
• FIXDIFPJOFIIEC-RITPCOANSA-N (3r)-3-hydroxy-n-[(3s)-2-oxooxolan-3-yl]butanamide Chemical compound C[C@@H](O)CC(=O)N[C@H]1CCOC1=O FIXDIFPJOFIIEC-RITPCOANSA-N 0.000 description 3
• 102000004899 14-3-3 Proteins Human genes 0.000 description 3
• 102000005666 Apolipoprotein A-I Human genes 0.000 description 3
• 108010059886 Apolipoprotein A-I Proteins 0.000 description 3
• 108010081589 Becaplermin Proteins 0.000 description 3
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 3
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 3
• 102100036850 C-C motif chemokine 23 Human genes 0.000 description 3
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 3
• 108010017987 CD30 Ligand Proteins 0.000 description 3
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
• 108090000317 Chymotrypsin Proteins 0.000 description 3
• 108010035532 Collagen Proteins 0.000 description 3
• 102000008186 Collagen Human genes 0.000 description 3
• 208000035473 Communicable disease Diseases 0.000 description 3
• 102400000498 Connective tissue-activating peptide III Human genes 0.000 description 3
• 108010087195 Contactin 1 Proteins 0.000 description 3
• 102100024326 Contactin-1 Human genes 0.000 description 3
• 102100024340 Contactin-4 Human genes 0.000 description 3
• 101710107714 Contactin-4 Proteins 0.000 description 3
• 238000000018 DNA microarray Methods 0.000 description 3
• 229940124143 Endopeptidase inhibitor Drugs 0.000 description 3
• 102000002090 Fibronectin type III Human genes 0.000 description 3
• 108050009401 Fibronectin type III Proteins 0.000 description 3
• 102000004878 Gelsolin Human genes 0.000 description 3
• 108090001064 Gelsolin Proteins 0.000 description 3
• 101000760084 Homo sapiens 14-3-3 protein eta Proteins 0.000 description 3
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 description 3
• 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 description 3
• 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 description 3
• 101001132652 Homo sapiens Retinoic acid receptor responder protein 2 Proteins 0.000 description 3
• 101000818543 Homo sapiens Tyrosine-protein kinase ZAP-70 Proteins 0.000 description 3
• 102000003839 Human Proteins Human genes 0.000 description 3
• 108090000144 Human Proteins Proteins 0.000 description 3
• 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 description 3
• 206010061218 Inflammation Diseases 0.000 description 3
• 102000004883 Insulin-like growth factor-binding protein 6 Human genes 0.000 description 3
• 108090001014 Insulin-like growth factor-binding protein 6 Proteins 0.000 description 3
• 108010078049 Interferon alpha-2 Proteins 0.000 description 3
• 102100039350 Interferon alpha-7 Human genes 0.000 description 3
• 108010002350 Interleukin-2 Proteins 0.000 description 3
• ZCYVEMRRCGMTRW-AHCXROLUSA-N Iodine-123 Chemical compound [123I] ZCYVEMRRCGMTRW-AHCXROLUSA-N 0.000 description 3
• 102100031607 Kunitz-type protease inhibitor 1 Human genes 0.000 description 3
• 101710165137 Kunitz-type protease inhibitor 1 Proteins 0.000 description 3
• 208000032420 Latent Infection Diseases 0.000 description 3
• 102000004895 Lipoproteins Human genes 0.000 description 3
• 108090001030 Lipoproteins Proteins 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
• 102000003896 Myeloperoxidases Human genes 0.000 description 3
• 108090000235 Myeloperoxidases Proteins 0.000 description 3
• 101710118230 Neutrophil collagenase Proteins 0.000 description 3
• 238000012408 PCR amplification Methods 0.000 description 3
• 108010058864 Phospholipases A2 Proteins 0.000 description 3
• 229920001213 Polysorbate 20 Polymers 0.000 description 3
• 229940096437 Protein S Drugs 0.000 description 3
• 108010066124 Protein S Proteins 0.000 description 3
• 102000029301 Protein S Human genes 0.000 description 3
• 238000011529 RT qPCR Methods 0.000 description 3
• 102100033914 Retinoic acid receptor responder protein 2 Human genes 0.000 description 3
• 102000008847 Serpin Human genes 0.000 description 3
• 108050000761 Serpin Proteins 0.000 description 3
• 229940100514 Syk tyrosine kinase inhibitor Drugs 0.000 description 3
• GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 3
• 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 3
• 102100021125 Tyrosine-protein kinase ZAP-70 Human genes 0.000 description 3
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
• 230000021736 acetylation Effects 0.000 description 3
• 238000006640 acetylation reaction Methods 0.000 description 3
• 230000004721 adaptive immunity Effects 0.000 description 3
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 3
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 3
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 3
• 230000033115 angiogenesis Effects 0.000 description 3
• 230000000844 anti-bacterial effect Effects 0.000 description 3
• 239000000427 antigen Chemical class 0.000 description 3
• 108091007433 antigens Chemical class 0.000 description 3
• 102000036639 antigens Human genes 0.000 description 3
• 239000004019 antithrombin Substances 0.000 description 3
• 238000003491 array Methods 0.000 description 3
• 238000000668 atmospheric pressure chemical ionisation mass spectrometry Methods 0.000 description 3
• 238000001854 atmospheric pressure photoionisation mass spectrometry Methods 0.000 description 3
• 239000000091 biomarker candidate Substances 0.000 description 3
• 238000001574 biopsy Methods 0.000 description 3
• 239000003114 blood coagulation factor Substances 0.000 description 3
• 229910052791 calcium Inorganic materials 0.000 description 3
• 239000011575 calcium Substances 0.000 description 3
• 230000009087 cell motility Effects 0.000 description 3
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
• 229960002376 chymotrypsin Drugs 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 229920001436 collagen Polymers 0.000 description 3
• 108010035886 connective tissue-activating peptide Proteins 0.000 description 3
• 230000018044 dehydration Effects 0.000 description 3
• 238000006297 dehydration reaction Methods 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 3
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 3
• 230000006862 enzymatic digestion Effects 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 239000000835 fiber Substances 0.000 description 3
• 238000005194 fractionation Methods 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• 238000011223 gene expression profiling Methods 0.000 description 3
• 239000008187 granular material Substances 0.000 description 3
• 239000003102 growth factor Substances 0.000 description 3
• 230000036541 health Effects 0.000 description 3
• 230000003862 health status Effects 0.000 description 3
• 238000012744 immunostaining Methods 0.000 description 3
• 238000007901 in situ hybridization Methods 0.000 description 3
• 230000004054 inflammatory process Effects 0.000 description 3
• 238000000370 laser capture micro-dissection Methods 0.000 description 3
• 210000000265 leukocyte Anatomy 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 230000033001 locomotion Effects 0.000 description 3
• 238000007726 management method Methods 0.000 description 3
• 238000005374 membrane filtration Methods 0.000 description 3
• 238000007837 multiplex assay Methods 0.000 description 3
• 238000010606 normalization Methods 0.000 description 3
• 235000015097 nutrients Nutrition 0.000 description 3
• 230000001717 pathogenic effect Effects 0.000 description 3
• 238000003909 pattern recognition Methods 0.000 description 3
• 230000026731 phosphorylation Effects 0.000 description 3
• 238000006366 phosphorylation reaction Methods 0.000 description 3
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
• 238000011176 pooling Methods 0.000 description 3
• 238000002600 positron emission tomography Methods 0.000 description 3
• 238000011002 quantification Methods 0.000 description 3
• 239000002096 quantum dot Substances 0.000 description 3
• 230000002285 radioactive effect Effects 0.000 description 3
• 238000003753 real-time PCR Methods 0.000 description 3
• 230000000241 respiratory effect Effects 0.000 description 3
• 238000003757 reverse transcription PCR Methods 0.000 description 3
• 230000011664 signaling Effects 0.000 description 3
• 238000002603 single-photon emission computed tomography Methods 0.000 description 3
• 230000015590 smooth muscle cell migration Effects 0.000 description 3
• 238000002791 soaking Methods 0.000 description 3
• 239000002904 solvent Substances 0.000 description 3
• 125000006850 spacer group Chemical group 0.000 description 3
• 230000009870 specific binding Effects 0.000 description 3
• 238000013179 statistical model Methods 0.000 description 3
• 230000009897 systematic effect Effects 0.000 description 3
• 229940056501 technetium 99m Drugs 0.000 description 3
• 229940124597 therapeutic agent Drugs 0.000 description 3
• 230000001988 toxicity Effects 0.000 description 3
• 231100000419 toxicity Toxicity 0.000 description 3
• 238000012800 visualization Methods 0.000 description 3
• 238000005406 washing Methods 0.000 description 3
• XJOTXKZIRSHZQV-RXHOOSIZSA-N (3S)-3-amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S,3S)-1-[[(1R,6R,12R,17R,20S,23S,26R,31R,34R,39R,42S,45S,48S,51S,59S)-51-(4-aminobutyl)-31-[[(2S)-6-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1-oxohexan-2-yl]carbamoyl]-20-benzyl-23-[(2S)-butan-2-yl]-45-(3-carbamimidamidopropyl)-48-(hydroxymethyl)-42-(1H-imidazol-4-ylmethyl)-59-(2-methylsulfanylethyl)-7,10,19,22,25,33,40,43,46,49,52,54,57,60,63,64-hexadecaoxo-3,4,14,15,28,29,36,37-octathia-8,11,18,21,24,32,41,44,47,50,53,55,58,61,62,65-hexadecazatetracyclo[32.19.8.26,17.212,39]pentahexacontan-26-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)[C@@H](C)O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@@H](NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1cnc[nH]1)NC3=O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N2)C(=O)NCC(=O)N4)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XJOTXKZIRSHZQV-RXHOOSIZSA-N 0.000 description 2
• 102100027832 14-3-3 protein gamma Human genes 0.000 description 2
• 101710191812 14-3-3 protein gamma Proteins 0.000 description 2
• 208000030507 AIDS Diseases 0.000 description 2
• WHVNXSBKJGAXKU-UHFFFAOYSA-N Alexa Fluor 532 Chemical compound [H+].[H+].CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)N=4)(C)C)=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C=C1)=CC=C1C(=O)ON1C(=O)CCC1=O WHVNXSBKJGAXKU-UHFFFAOYSA-N 0.000 description 2
• 239000012099 Alexa Fluor family Substances 0.000 description 2
• 102100035028 Alpha-L-iduronidase Human genes 0.000 description 2
• 102400000068 Angiostatin Human genes 0.000 description 2
• 108010079709 Angiostatins Proteins 0.000 description 2
• 108010049777 Ankyrins Proteins 0.000 description 2
• 102000008102 Ankyrins Human genes 0.000 description 2
• 108010031480 Artificial Receptors Proteins 0.000 description 2
• 206010003445 Ascites Diseases 0.000 description 2
• 102100035882 Catalase Human genes 0.000 description 2
• 108010053835 Catalase Proteins 0.000 description 2
• 102100031615 Ciliary neurotrophic factor receptor subunit alpha Human genes 0.000 description 2
• 102100023804 Coagulation factor VII Human genes 0.000 description 2
• 108010078015 Complement C3b Proteins 0.000 description 2
• 108090000056 Complement factor B Proteins 0.000 description 2
• 102000003712 Complement factor B Human genes 0.000 description 2
• 102100024343 Contactin-5 Human genes 0.000 description 2
• 101710107709 Contactin-5 Proteins 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 108091008102 DNA aptamers Proteins 0.000 description 2
• 206010061818 Disease progression Diseases 0.000 description 2
• 206010061819 Disease recurrence Diseases 0.000 description 2
• 102100024361 Disintegrin and metalloproteinase domain-containing protein 9 Human genes 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 102100030322 Ephrin type-A receptor 1 Human genes 0.000 description 2
• 101710116744 Ephrin type-A receptor 1 Proteins 0.000 description 2
• 101710127949 Extracellular matrix protein 1 Proteins 0.000 description 2
• 238000004252 FT/ICR mass spectrometry Methods 0.000 description 2
• 108010023321 Factor VII Proteins 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 102100033299 Glia-derived nexin Human genes 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 102000003693 Hedgehog Proteins Human genes 0.000 description 2
• 108090000031 Hedgehog Proteins Proteins 0.000 description 2
• 102000001554 Hemoglobins Human genes 0.000 description 2
• 108010054147 Hemoglobins Proteins 0.000 description 2
• 101001019502 Homo sapiens Alpha-L-iduronidase Proteins 0.000 description 2
• 101001126865 Homo sapiens Biglycan Proteins 0.000 description 2
• 101000993348 Homo sapiens Ciliary neurotrophic factor receptor subunit alpha Proteins 0.000 description 2
• 101001021404 Homo sapiens G-protein coupled receptor-associated sorting protein 2 Proteins 0.000 description 2
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 2
• 101000756805 Homo sapiens Repulsive guidance molecule B Proteins 0.000 description 2
• 101000894525 Homo sapiens Transforming growth factor-beta-induced protein ig-h3 Proteins 0.000 description 2
• 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 2
• 101001003187 Hordeum vulgare Alpha-amylase/subtilisin inhibitor Proteins 0.000 description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 102000004157 Hydrolases Human genes 0.000 description 2
• 108090000604 Hydrolases Proteins 0.000 description 2
• 108060003951 Immunoglobulin Proteins 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• 102000004371 Insulin-like growth factor binding protein 5 Human genes 0.000 description 2
• 108090000961 Insulin-like growth factor binding protein 5 Proteins 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 238000012773 Laboratory assay Methods 0.000 description 2
• 108090001090 Lectins Proteins 0.000 description 2
• 102000004856 Lectins Human genes 0.000 description 2
• 102100028263 Limbic system-associated membrane protein Human genes 0.000 description 2
• 101710162762 Limbic system-associated membrane protein Proteins 0.000 description 2
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 2
• 238000000585 Mann–Whitney U test Methods 0.000 description 2
• 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
• 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 2
• 102100026261 Metalloproteinase inhibitor 3 Human genes 0.000 description 2
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
• 108090000189 Neuropeptides Proteins 0.000 description 2
• 101100202932 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) tsp-4 gene Proteins 0.000 description 2
• 102100033223 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 2
• 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• 102000003992 Peroxidases Human genes 0.000 description 2
• 102000007456 Peroxiredoxin Human genes 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
• 102000017975 Protein C Human genes 0.000 description 2
• 101800004937 Protein C Proteins 0.000 description 2
• 102100027378 Prothrombin Human genes 0.000 description 2
• 108010094028 Prothrombin Proteins 0.000 description 2
• 108091008103 RNA aptamers Proteins 0.000 description 2
• 101100208249 Rattus norvegicus Thbs4 gene Proteins 0.000 description 2
• 108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 description 2
• 102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 description 2
• 102100022814 Repulsive guidance molecule B Human genes 0.000 description 2
• 102000018968 Salivary Cystatins Human genes 0.000 description 2
• 108010026774 Salivary Cystatins Proteins 0.000 description 2
• 101800001700 Saposin-D Proteins 0.000 description 2
• 108010005113 Serpin E2 Proteins 0.000 description 2
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 2
• 108020004682 Single-Stranded DNA Proteins 0.000 description 2
• 108090000190 Thrombin Proteins 0.000 description 2
• 102000002248 Thyroxine-Binding Globulin Human genes 0.000 description 2
• 108010000259 Thyroxine-Binding Globulin Proteins 0.000 description 2
• 102000009488 Thyroxine-Binding Proteins Human genes 0.000 description 2
• 108010048889 Thyroxine-Binding Proteins Proteins 0.000 description 2
• 108010031429 Tissue Inhibitor of Metalloproteinase-3 Proteins 0.000 description 2
• 102100021398 Transforming growth factor-beta-induced protein ig-h3 Human genes 0.000 description 2
• 206010066901 Treatment failure Diseases 0.000 description 2
• 102100032807 Tumor necrosis factor-inducible gene 6 protein Human genes 0.000 description 2
• 101710169430 Tumor necrosis factor-inducible gene 6 protein Proteins 0.000 description 2
• 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 2
• 238000001793 Wilcoxon signed-rank test Methods 0.000 description 2
• 230000005856 abnormality Effects 0.000 description 2
• 230000001154 acute effect Effects 0.000 description 2
• 238000007792 addition Methods 0.000 description 2
• 230000002776 aggregation Effects 0.000 description 2
• 238000004220 aggregation Methods 0.000 description 2
• 230000003466 anti-cipated effect Effects 0.000 description 2
• 230000030741 antigen processing and presentation Effects 0.000 description 2
• 230000006907 apoptotic process Effects 0.000 description 2
• YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
• 230000001174 ascending effect Effects 0.000 description 2
• FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 2
• 125000004429 atom Chemical group 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• 230000005540 biological transmission Effects 0.000 description 2
• 230000029918 bioluminescence Effects 0.000 description 2
• 238000005415 bioluminescence Methods 0.000 description 2
• 230000023555 blood coagulation Effects 0.000 description 2
• 238000006664 bond formation reaction Methods 0.000 description 2
• 238000005251 capillar electrophoresis Methods 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000012292 cell migration Effects 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 229940105772 coagulation factor vii Drugs 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 238000002591 computed tomography Methods 0.000 description 2
• 230000021615 conjugation Effects 0.000 description 2
• 238000012937 correction Methods 0.000 description 2
• 229940124446 critical care medicine Drugs 0.000 description 2
• 238000004132 cross linking Methods 0.000 description 2
• 230000009260 cross reactivity Effects 0.000 description 2
• 102000003675 cytokine receptors Human genes 0.000 description 2
• 108010057085 cytokine receptors Proteins 0.000 description 2
• 210000000805 cytoplasm Anatomy 0.000 description 2
• 238000013480 data collection Methods 0.000 description 2
• 238000007418 data mining Methods 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 231100000517 death Toxicity 0.000 description 2
• 230000004040 defense response to microbe Effects 0.000 description 2
• 230000009274 differential gene expression Effects 0.000 description 2
• 230000005750 disease progression Effects 0.000 description 2
• 239000012153 distilled water Substances 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 210000003743 erythrocyte Anatomy 0.000 description 2
• 229960000285 ethambutol Drugs 0.000 description 2
• 238000010195 expression analysis Methods 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 230000020764 fibrinolysis Effects 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 238000007710 freezing Methods 0.000 description 2
• 230000008014 freezing Effects 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 230000005182 global health Effects 0.000 description 2
• 150000004676 glycans Chemical class 0.000 description 2
• 230000036252 glycation Effects 0.000 description 2
• 239000001963 growth medium Substances 0.000 description 2
• 230000002489 hematologic effect Effects 0.000 description 2
• 102000018511 hepcidin Human genes 0.000 description 2
• 108060003558 hepcidin Proteins 0.000 description 2
• 229940066919 hepcidin Drugs 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 108091008039 hormone receptors Proteins 0.000 description 2
• 230000003100 immobilizing effect Effects 0.000 description 2
• 102000018358 immunoglobulin Human genes 0.000 description 2
• 238000001114 immunoprecipitation Methods 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 230000008595 infiltration Effects 0.000 description 2
• 238000001764 infiltration Methods 0.000 description 2
• 229910052742 iron Inorganic materials 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 229960003350 isoniazid Drugs 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 238000001001 laser micro-dissection Methods 0.000 description 2
• 239000002523 lectin Substances 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 238000012417 linear regression Methods 0.000 description 2
• 230000029226 lipidation Effects 0.000 description 2
• 238000009630 liquid culture Methods 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• 239000006166 lysate Substances 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 238000002595 magnetic resonance imaging Methods 0.000 description 2
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 229910021645 metal ion Inorganic materials 0.000 description 2
• 230000011987 methylation Effects 0.000 description 2
• 238000007069 methylation reaction Methods 0.000 description 2
• 238000001531 micro-dissection Methods 0.000 description 2
• 230000000813 microbial effect Effects 0.000 description 2
• 238000000386 microscopy Methods 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 239000012120 mounting media Substances 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• 230000000926 neurological effect Effects 0.000 description 2
• 210000000440 neutrophil Anatomy 0.000 description 2
• 238000003203 nucleic acid sequencing method Methods 0.000 description 2
• 230000035764 nutrition Effects 0.000 description 2
• 235000016709 nutrition Nutrition 0.000 description 2
• 238000012634 optical imaging Methods 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
• 230000003076 paracrine Effects 0.000 description 2
• 239000013610 patient sample Substances 0.000 description 2
• 239000000816 peptidomimetic Substances 0.000 description 2
• 108040007629 peroxidase activity proteins Proteins 0.000 description 2
• 108030002458 peroxiredoxin Proteins 0.000 description 2
• 230000035790 physiological processes and functions Effects 0.000 description 2
• 229940012957 plasmin Drugs 0.000 description 2
• 229920001282 polysaccharide Polymers 0.000 description 2
• 239000005017 polysaccharide Substances 0.000 description 2
• 238000001556 precipitation Methods 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 238000000513 principal component analysis Methods 0.000 description 2
• 230000002035 prolonged effect Effects 0.000 description 2
• 229960000856 protein c Drugs 0.000 description 2
• 229940039716 prothrombin Drugs 0.000 description 2
• 238000010384 proximity ligation assay Methods 0.000 description 2
• 229960005206 pyrazinamide Drugs 0.000 description 2
• IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 2
• WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 229960002599 rifapentine Drugs 0.000 description 2
• WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 description 2
• 238000005096 rolling process Methods 0.000 description 2
• 238000003196 serial analysis of gene expression Methods 0.000 description 2
• 230000019491 signal transduction Effects 0.000 description 2
• 239000000377 silicon dioxide Substances 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 238000007619 statistical method Methods 0.000 description 2
• 239000003270 steroid hormone Substances 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 230000000153 supplemental effect Effects 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 238000010189 synthetic method Methods 0.000 description 2
• UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
• 229960004072 thrombin Drugs 0.000 description 2
• XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 230000001131 transforming effect Effects 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• 230000032739 trivalent inorganic cation homeostasis Effects 0.000 description 2
• 238000000539 two dimensional gel electrophoresis Methods 0.000 description 2
• 230000004580 weight loss Effects 0.000 description 2
• YYLQUHNPNCGKJQ-NHYDCYSISA-N (3R)-3-hydroxy-L-aspartic acid Chemical compound OC(=O)[C@@H](N)[C@@H](O)C(O)=O YYLQUHNPNCGKJQ-NHYDCYSISA-N 0.000 description 1
• CBXRMKZFYQISIV-UHFFFAOYSA-N 1-n,1-n,1-n',1-n',2-n,2-n,2-n',2-n'-octamethylethene-1,1,2,2-tetramine Chemical group CN(C)C(N(C)C)=C(N(C)C)N(C)C CBXRMKZFYQISIV-UHFFFAOYSA-N 0.000 description 1
• PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 1
• 101710112984 20 kDa protein Proteins 0.000 description 1
• ZDRVLAOYDGQLFI-UHFFFAOYSA-N 4-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino]phenol;hydrochloride Chemical compound Cl.C1=CC(O)=CC=C1NC1=NC(C=2C=CC(Cl)=CC=2)=CS1 ZDRVLAOYDGQLFI-UHFFFAOYSA-N 0.000 description 1
• 102100035274 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 Human genes 0.000 description 1
• 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
• 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
• MPVDXIMFBOLMNW-ISLYRVAYSA-N 7-hydroxy-8-[(E)-phenyldiazenyl]naphthalene-1,3-disulfonic acid Chemical compound OC1=CC=C2C=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=C1\N=N\C1=CC=CC=C1 MPVDXIMFBOLMNW-ISLYRVAYSA-N 0.000 description 1
• 102400000069 Activation peptide Human genes 0.000 description 1
• 101800001401 Activation peptide Proteins 0.000 description 1
• 206010048998 Acute phase reaction Diseases 0.000 description 1
• 102000011767 Acute-Phase Proteins Human genes 0.000 description 1
• 108010062271 Acute-Phase Proteins Proteins 0.000 description 1
• 102000014777 Adipokines Human genes 0.000 description 1
• 108010078606 Adipokines Proteins 0.000 description 1
• 239000012103 Alexa Fluor 488 Substances 0.000 description 1
• 239000012114 Alexa Fluor 647 Substances 0.000 description 1
• 239000012116 Alexa Fluor 680 Substances 0.000 description 1
• 239000012117 Alexa Fluor 700 Substances 0.000 description 1
• 102100040121 Allograft inflammatory factor 1 Human genes 0.000 description 1
• QGZKDVFQNNGYKY-OUBTZVSYSA-N Ammonia-15N Chemical compound [15NH3] QGZKDVFQNNGYKY-OUBTZVSYSA-N 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 101710081722 Antitrypsin Proteins 0.000 description 1
• 108010060215 Apolipoprotein E3 Proteins 0.000 description 1
• 102000008128 Apolipoprotein E3 Human genes 0.000 description 1
• 108010060159 Apolipoprotein E4 Proteins 0.000 description 1
• 102100038238 Aromatic-L-amino-acid decarboxylase Human genes 0.000 description 1
• 108090000461 Aurora Kinase A Proteins 0.000 description 1
• 102100032311 Aurora kinase A Human genes 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 241000304886 Bacilli Species 0.000 description 1
• 108091032955 Bacterial small RNA Proteins 0.000 description 1
• 102100021738 Beta-adrenergic receptor kinase 1 Human genes 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 102100030401 Biglycan Human genes 0.000 description 1
• ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 1
• 102000053028 CD36 Antigens Human genes 0.000 description 1
• 108010045374 CD36 Antigens Proteins 0.000 description 1
• 102100026862 CD5 antigen-like Human genes 0.000 description 1
• 102000000905 Cadherin Human genes 0.000 description 1
• 108050007957 Cadherin Proteins 0.000 description 1
• 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
• 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
• 102000007590 Calpain Human genes 0.000 description 1
• 108010032088 Calpain Proteins 0.000 description 1
• 102100035037 Calpastatin Human genes 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 102000003908 Cathepsin D Human genes 0.000 description 1
• 108090000258 Cathepsin D Proteins 0.000 description 1
• 102100024046 Cell adhesion molecule 3 Human genes 0.000 description 1
• 101710197433 Cell adhesion molecule 3 Proteins 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 208000007190 Chlamydia Infections Diseases 0.000 description 1
• 208000017667 Chronic Disease Diseases 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 241000207199 Citrus Species 0.000 description 1
• 102100031552 Coactosin-like protein Human genes 0.000 description 1
• 101710105549 Coactosin-like protein Proteins 0.000 description 1
• 101000973921 Coccidioides posadasii (strain C735) Neutral protease 2 homolog MEP8 Proteins 0.000 description 1
• 108090000996 Cofilin 1 Proteins 0.000 description 1
• 102100027466 Cofilin-1 Human genes 0.000 description 1
• 208000003322 Coinfection Diseases 0.000 description 1
• 108090000909 Collectins Proteins 0.000 description 1
• 102000004405 Collectins Human genes 0.000 description 1
• 229920000742 Cotton Polymers 0.000 description 1
• 206010011224 Cough Diseases 0.000 description 1
• 102000015833 Cystatin Human genes 0.000 description 1
• 108010061642 Cystatin C Proteins 0.000 description 1
• 102000012177 Cystatin M Human genes 0.000 description 1
• 108010061617 Cystatin M Proteins 0.000 description 1
• 102100026897 Cystatin-C Human genes 0.000 description 1
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical group OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
• 102100037986 Dickkopf-related protein 4 Human genes 0.000 description 1
• 101710099554 Dickkopf-related protein 4 Proteins 0.000 description 1
• BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical class C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
• 101710116121 Disintegrin and metalloproteinase domain-containing protein 9 Proteins 0.000 description 1
• 206010059866 Drug resistance Diseases 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 101150049192 ERP29 gene Proteins 0.000 description 1
• 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 description 1
• 206010063045 Effusion Diseases 0.000 description 1
• 108010014258 Elastin Proteins 0.000 description 1
• 102000016942 Elastin Human genes 0.000 description 1
• 102100037241 Endoglin Human genes 0.000 description 1
• 108010036395 Endoglin Proteins 0.000 description 1
• 102000005593 Endopeptidases Human genes 0.000 description 1
• 108010059378 Endopeptidases Proteins 0.000 description 1
• 102100031857 Endoplasmic reticulum resident protein 29 Human genes 0.000 description 1
• 102000010911 Enzyme Precursors Human genes 0.000 description 1
• 108010062466 Enzyme Precursors Proteins 0.000 description 1
• 108010043939 Ephrin-A5 Proteins 0.000 description 1
• 102100033941 Ephrin-A5 Human genes 0.000 description 1
• 108010073385 Fibrin Proteins 0.000 description 1
• 102000009123 Fibrin Human genes 0.000 description 1
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
• 238000000729 Fisher's exact test Methods 0.000 description 1
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• 229910052688 Gadolinium Inorganic materials 0.000 description 1
• 108010015133 Galactose oxidase Proteins 0.000 description 1
• 102000006395 Globulins Human genes 0.000 description 1
• 108010044091 Globulins Proteins 0.000 description 1
• 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
• 102100022624 Glucoamylase Human genes 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 108010015776 Glucose oxidase Proteins 0.000 description 1
• 239000004366 Glucose oxidase Substances 0.000 description 1
• 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
• 229920002527 Glycogen Polymers 0.000 description 1
• 108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 description 1
• 102100038104 Glycogen synthase kinase-3 beta Human genes 0.000 description 1
• 206010018691 Granuloma Diseases 0.000 description 1
• 102100020948 Growth hormone receptor Human genes 0.000 description 1
• 102100040898 Growth/differentiation factor 11 Human genes 0.000 description 1
• 101710194452 Growth/differentiation factor 11 Proteins 0.000 description 1
• 206010018910 Haemolysis Diseases 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 102100031465 Hepatocyte growth factor activator Human genes 0.000 description 1
• 101710085796 Hepatocyte growth factor activator Proteins 0.000 description 1
• 244000043261 Hevea brasiliensis Species 0.000 description 1
• 102100035042 Histone-lysine N-methyltransferase EHMT2 Human genes 0.000 description 1
• 101001022183 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 Proteins 0.000 description 1
• 101000890626 Homo sapiens Allograft inflammatory factor 1 Proteins 0.000 description 1
• 101000751445 Homo sapiens Beta-adrenergic receptor kinase 1 Proteins 0.000 description 1
• 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 1
• 101000911996 Homo sapiens CD5 antigen-like Proteins 0.000 description 1
• 101000864646 Homo sapiens Dickkopf-related protein 1 Proteins 0.000 description 1
• 101000832769 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 9 Proteins 0.000 description 1
• 101100225546 Homo sapiens EHMT2 gene Proteins 0.000 description 1
• 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 description 1
• 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 description 1
• 101001081567 Homo sapiens Insulin-like growth factor-binding protein 1 Proteins 0.000 description 1
• 101001002469 Homo sapiens Interferon lambda-2 Proteins 0.000 description 1
• 101001042527 Homo sapiens Leucine carboxyl methyltransferase 1 Proteins 0.000 description 1
• 101001054921 Homo sapiens Lymphatic vessel endothelial hyaluronic acid receptor 1 Proteins 0.000 description 1
• 101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 description 1
• 101000958771 Homo sapiens N-acylethanolamine-hydrolyzing acid amidase Proteins 0.000 description 1
• 101001070790 Homo sapiens Platelet glycoprotein Ib alpha chain Proteins 0.000 description 1
• 101001097889 Homo sapiens Platelet-activating factor acetylhydrolase Proteins 0.000 description 1
• 101001064282 Homo sapiens Platelet-activating factor acetylhydrolase IB subunit beta Proteins 0.000 description 1
• 101001130509 Homo sapiens Ras GTPase-activating protein 1 Proteins 0.000 description 1
• 101000756808 Homo sapiens Repulsive guidance molecule A Proteins 0.000 description 1
• 101000863883 Homo sapiens Sialic acid-binding Ig-like lectin 9 Proteins 0.000 description 1
• 101000795085 Homo sapiens Tryptase beta-2 Proteins 0.000 description 1
• 101000920026 Homo sapiens Tumor necrosis factor receptor superfamily member EDAR Proteins 0.000 description 1
• 206010020608 Hypercoagulation Diseases 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• 238000004566 IR spectroscopy Methods 0.000 description 1
• 102000043333 Immunoglobulin I-set Human genes 0.000 description 1
• 108700038397 Immunoglobulin I-set Proteins 0.000 description 1
• 102000018297 Immunoglobulin subtype Human genes 0.000 description 1
• 108050007411 Immunoglobulin subtype Proteins 0.000 description 1
• 102000018294 Immunoglobulin subtype 2 Human genes 0.000 description 1
• 108050007414 Immunoglobulin subtype 2 Proteins 0.000 description 1
• 206010022489 Insulin Resistance Diseases 0.000 description 1
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
• 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 description 1
• 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 description 1
• 102100027636 Insulin-like growth factor-binding protein 1 Human genes 0.000 description 1
• 102100020989 Interferon lambda-2 Human genes 0.000 description 1
• 229940119497 Interleukin 11 receptor antagonist Drugs 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 102000000589 Interleukin-1 Human genes 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102100026236 Interleukin-8 Human genes 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 102100035792 Kininogen-1 Human genes 0.000 description 1
• 108010077861 Kininogens Proteins 0.000 description 1
• 238000001276 Kolmogorov–Smirnov test Methods 0.000 description 1
• 150000008575 L-amino acids Chemical class 0.000 description 1
• 238000007397 LAMP assay Methods 0.000 description 1
• 102100038609 Lactoperoxidase Human genes 0.000 description 1
• 108010023244 Lactoperoxidase Proteins 0.000 description 1
• 102100021737 Leucine carboxyl methyltransferase 1 Human genes 0.000 description 1
• HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
• 208000008771 Lymphadenopathy Diseases 0.000 description 1
• 102100026849 Lymphatic vessel endothelial hyaluronic acid receptor 1 Human genes 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
• 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
• 108010031099 Mannose Receptor Proteins 0.000 description 1
• 108010072582 Matrilin Proteins Proteins 0.000 description 1
• 102100033669 Matrilin-2 Human genes 0.000 description 1
• 208000001145 Metabolic Syndrome Diseases 0.000 description 1
• 102000005741 Metalloproteases Human genes 0.000 description 1
• 108010006035 Metalloproteases Proteins 0.000 description 1
• 108050006602 Metalloproteinase inhibitor 2 Proteins 0.000 description 1
• 102100023174 Methionine aminopeptidase 2 Human genes 0.000 description 1
• 108090000192 Methionyl aminopeptidases Proteins 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 108700011259 MicroRNAs Proteins 0.000 description 1
• 102100030335 Midkine Human genes 0.000 description 1
• 108010092801 Midkine Proteins 0.000 description 1
• 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
• 101710159910 Movement protein Proteins 0.000 description 1
• 102100030856 Myoglobin Human genes 0.000 description 1
• 108010062374 Myoglobin Proteins 0.000 description 1
• 102100038360 N-acylethanolamine-hydrolyzing acid amidase Human genes 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 206010029113 Neovascularisation Diseases 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 108090000772 Neuropilin-1 Proteins 0.000 description 1
• 108030001564 Neutrophil collagenases Proteins 0.000 description 1
• 244000061176 Nicotiana tabacum Species 0.000 description 1
• 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• QJGQUHMNIGDVPM-BJUDXGSMSA-N Nitrogen-13 Chemical compound [13N] QJGQUHMNIGDVPM-BJUDXGSMSA-N 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 108091028043 Nucleic acid sequence Proteins 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 102100026742 Opioid-binding protein/cell adhesion molecule Human genes 0.000 description 1
• 101710096745 Opioid-binding protein/cell adhesion molecule Proteins 0.000 description 1
• 102100025386 Oxidized low-density lipoprotein receptor 1 Human genes 0.000 description 1
• 229910019142 PO4 Chemical group 0.000 description 1
• 229940122344 Peptidase inhibitor Drugs 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 108010043958 Peptoids Proteins 0.000 description 1
• 101710096328 Phospholipase A2 Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 102100034173 Platelet glycoprotein Ib alpha chain Human genes 0.000 description 1
• 102100037518 Platelet-activating factor acetylhydrolase Human genes 0.000 description 1
• 206010035720 Pneumonia lipoid Diseases 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 239000004743 Polypropylene Substances 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 102100023068 Protein kinase C-binding protein NELL1 Human genes 0.000 description 1
• 108010026552 Proteome Proteins 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 108010066717 Q beta Replicase Proteins 0.000 description 1
• 238000001069 Raman spectroscopy Methods 0.000 description 1
• 102100031426 Ras GTPase-activating protein 1 Human genes 0.000 description 1
• 230000010799 Receptor Interactions Effects 0.000 description 1
• 102100025234 Receptor of activated protein C kinase 1 Human genes 0.000 description 1
• 108010044157 Receptors for Activated C Kinase Proteins 0.000 description 1
• 208000035415 Reinfection Diseases 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 102100022813 Repulsive guidance molecule A Human genes 0.000 description 1
• 102000007156 Resistin Human genes 0.000 description 1
• 108010047909 Resistin Proteins 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 229940122055 Serine protease inhibitor Drugs 0.000 description 1
• 101710102218 Serine protease inhibitor Proteins 0.000 description 1
• 101710187074 Serine proteinase inhibitor Proteins 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 description 1
• BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 108010068542 Somatotropin Receptors Proteins 0.000 description 1
• 102100036428 Spondin-1 Human genes 0.000 description 1
• 101710092167 Spondin-1 Proteins 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
• 101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
• 230000006052 T cell proliferation Effects 0.000 description 1
• 108091046915 Threose nucleic acid Proteins 0.000 description 1
• 102000002938 Thrombospondin Human genes 0.000 description 1
• 108060008245 Thrombospondin Proteins 0.000 description 1
• 102100030951 Tissue factor pathway inhibitor Human genes 0.000 description 1
• 102000010208 Transforming growth factor-beta-induced protein ig-h3 Human genes 0.000 description 1
• 108050001894 Transforming growth factor-beta-induced protein ig-h3 Proteins 0.000 description 1
• 102000014701 Transketolase Human genes 0.000 description 1
• 108010043652 Transketolase Proteins 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 102100029637 Tryptase beta-2 Human genes 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 108010065323 Tumor Necrosis Factor Ligand Superfamily Member 13 Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 102100030810 Tumor necrosis factor receptor superfamily member EDAR Human genes 0.000 description 1
• 108010035075 Tyrosine decarboxylase Proteins 0.000 description 1
• 238000011497 Univariate linear regression Methods 0.000 description 1
• 108010092464 Urate Oxidase Proteins 0.000 description 1
• 108010046334 Urease Proteins 0.000 description 1
• 208000032594 Vascular Remodeling Diseases 0.000 description 1
• 206010047115 Vasculitis Diseases 0.000 description 1
• 101710090398 Viral interleukin-10 homolog Proteins 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 229930003448 Vitamin K Natural products 0.000 description 1
• 102000013814 Wnt Human genes 0.000 description 1
• 108050003627 Wnt Proteins 0.000 description 1
• 102100033220 Xanthine oxidase Human genes 0.000 description 1
• 108010093894 Xanthine oxidase Proteins 0.000 description 1
• 101000998548 Yersinia ruckeri Alkaline proteinase inhibitor Proteins 0.000 description 1
• IZOBIZVXEKNCNN-ZNQIEUMMSA-N [(1r,2r,3's,4e,5s)-4-hexa-2,4-diynylidenespiro[3,6-dioxabicyclo[3.1.0]hexane-2,6'-oxane]-3'-yl] 3-methylbutanoate Chemical compound CC#CC#C\C=C([C@H]1O[C@H]11)\O[C@@]21CC[C@H](OC(=O)CC(C)C)CO2 IZOBIZVXEKNCNN-ZNQIEUMMSA-N 0.000 description 1
• YURITHJXMHIFRI-OUAFTQCISA-N [(2R)-1-[[(1S,2R,3S,4R,5R,6S)-3-[(2R,3R,4R,5S,6R)-3-amino-5-[(2R,3S,4S,5S,6R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-6-[[(2S,3S,4S,5S,6R)-6-[[2-aminoethoxy(hydroxy)phosphoryl]oxymethyl]-3-[(2R,3S,4S,5S,6R)-6-[[2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]ethoxy-hydroxyphosphoryl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-4,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hexadecanoyloxy-4,5,6-trihydroxycyclohexyl]oxy-hydroxyphosphoryl]oxy-3-octadecoxypropan-2-yl] docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCCCCCCCCC)COP(O)(=O)O[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO[C@H]4O[C@H](COP(O)(=O)OCCN)[C@@H](O)[C@H](O)[C@@H]4O[C@H]4O[C@H](COP(O)(=O)OCCNC(=O)[C@@H](N)CO)[C@@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H](O)[C@@H]3OP(O)(=O)OCCN)[C@H](O)[C@H]2N)[C@H]1OC(=O)CCCCCCCCCCCCCCC YURITHJXMHIFRI-OUAFTQCISA-N 0.000 description 1
• 230000003187 abdominal effect Effects 0.000 description 1
• 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
• KRHYYFGTRYWZRS-BJUDXGSMSA-N ac1l2y5h Chemical compound [18FH] KRHYYFGTRYWZRS-BJUDXGSMSA-N 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 230000010398 acute inflammatory response Effects 0.000 description 1
• 206010000891 acute myocardial infarction Diseases 0.000 description 1
• 230000004658 acute-phase response Effects 0.000 description 1
• 208000013228 adenopathy Diseases 0.000 description 1
• 239000000478 adipokine Substances 0.000 description 1
• 210000000577 adipose tissue Anatomy 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 108010004469 allophycocyanin Proteins 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 210000004381 amniotic fluid Anatomy 0.000 description 1
• 206010002022 amyloidosis Diseases 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 230000001475 anti-trypsic effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 238000011203 antimicrobial therapy Methods 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• 229940114079 arachidonic acid Drugs 0.000 description 1
• 235000021342 arachidonic acid Nutrition 0.000 description 1
• 238000013528 artificial neural network Methods 0.000 description 1
• 210000003567 ascitic fluid Anatomy 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 238000004630 atomic force microscopy Methods 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 235000021028 berry Nutrition 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 239000002981 blocking agent Substances 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 229920005549 butyl rubber Polymers 0.000 description 1
• 108010044208 calpastatin Proteins 0.000 description 1
• ZXJCOYBPXOBJMU-HSQGJUDPSA-N calpastatin peptide Ac 184-210 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(O)=O)NC(C)=O)[C@@H](C)O)C1=CC=C(O)C=C1 ZXJCOYBPXOBJMU-HSQGJUDPSA-N 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• OKTJSMMVPCPJKN-BJUDXGSMSA-N carbon-11 Chemical compound [11C] OKTJSMMVPCPJKN-BJUDXGSMSA-N 0.000 description 1
• UHBYWPGGCSDKFX-UHFFFAOYSA-N carboxyglutamic acid Chemical compound OC(=O)C(N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-UHFFFAOYSA-N 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000008619 cell matrix interaction Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 238000003392 chemiluminescence resonance energy transfer Methods 0.000 description 1
• PRQROPMIIGLWRP-BZSNNMDCSA-N chemotactic peptide Chemical class CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-BZSNNMDCSA-N 0.000 description 1
• 230000035605 chemotaxis Effects 0.000 description 1
• 238000011976 chest X-ray Methods 0.000 description 1
• 239000003593 chromogenic compound Substances 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 210000004081 cilia Anatomy 0.000 description 1
• 210000003040 circulating cell Anatomy 0.000 description 1
• 235000020971 citrus fruits Nutrition 0.000 description 1
• 230000011382 collagen catabolic process Effects 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 239000002131 composite material Substances 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 238000010411 cooking Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• 210000002726 cyst fluid Anatomy 0.000 description 1
• 108050004038 cystatin Proteins 0.000 description 1
• 230000003583 cytomorphological effect Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
• 238000013502 data validation Methods 0.000 description 1
• 238000003066 decision tree Methods 0.000 description 1
• 238000005202 decontamination Methods 0.000 description 1
• 230000003588 decontaminative effect Effects 0.000 description 1
• 230000004665 defense response Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 239000000104 diagnostic biomarker Substances 0.000 description 1
• 238000002059 diagnostic imaging Methods 0.000 description 1
• 239000012502 diagnostic product Substances 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• 239000013024 dilution buffer Substances 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 238000002651 drug therapy Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 238000013399 early diagnosis Methods 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 229920002549 elastin Polymers 0.000 description 1
• 230000005611 electricity Effects 0.000 description 1
• 238000000835 electrochemical detection Methods 0.000 description 1
• 238000011209 electrochromatography Methods 0.000 description 1
• 230000005264 electron capture Effects 0.000 description 1
• 238000002101 electrospray ionisation tandem mass spectrometry Methods 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 238000000295 emission spectrum Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 239000002532 enzyme inhibitor Substances 0.000 description 1
• 229940125532 enzyme inhibitor Drugs 0.000 description 1
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
• SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
• 230000008029 eradication Effects 0.000 description 1
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
• 238000011985 exploratory data analysis Methods 0.000 description 1
• 238000005562 fading Methods 0.000 description 1
• 235000013861 fat-free Nutrition 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 230000012953 feeding on blood of other organism Effects 0.000 description 1
• 229950003499 fibrin Drugs 0.000 description 1
• 230000003176 fibrotic effect Effects 0.000 description 1
• 230000009795 fibrotic process Effects 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 238000007667 floating Methods 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 238000002875 fluorescence polarization Methods 0.000 description 1
• 238000001506 fluorescence spectroscopy Methods 0.000 description 1
• 210000000497 foam cell Anatomy 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
• 230000005251 gamma ray Effects 0.000 description 1
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
• 230000000762 glandular Effects 0.000 description 1
• 229940116332 glucose oxidase Drugs 0.000 description 1
• 235000019420 glucose oxidase Nutrition 0.000 description 1
• 229940096919 glycogen Drugs 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 208000010758 granulomatous inflammation Diseases 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 229960000789 guanidine hydrochloride Drugs 0.000 description 1
• PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
• ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
• 210000005003 heart tissue Anatomy 0.000 description 1
• 230000008588 hemolysis Effects 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 230000001146 hypoxic effect Effects 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 230000000984 immunochemical effect Effects 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 238000011532 immunohistochemical staining Methods 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 238000007373 indentation Methods 0.000 description 1
• APFVFJFRJDLVQX-AHCXROLUSA-N indium-111 Chemical compound [111In] APFVFJFRJDLVQX-AHCXROLUSA-N 0.000 description 1
• 229940055742 indium-111 Drugs 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 210000005007 innate immune system Anatomy 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 239000011147 inorganic material Substances 0.000 description 1
• 229940096397 interleukin-8 Drugs 0.000 description 1
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
• 238000005040 ion trap Methods 0.000 description 1
• 238000000534 ion trap mass spectrometry Methods 0.000 description 1
• 238000001948 isotopic labelling Methods 0.000 description 1
• 208000017169 kidney disease Diseases 0.000 description 1
• 238000009533 lab test Methods 0.000 description 1
• 229940057428 lactoperoxidase Drugs 0.000 description 1
• 229960001614 levamisole Drugs 0.000 description 1
• 238000007834 ligase chain reaction Methods 0.000 description 1
• 230000002366 lipolytic effect Effects 0.000 description 1
• 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 description 1
• 238000004811 liquid chromatography Methods 0.000 description 1
• MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 1
• 229910001486 lithium perchlorate Inorganic materials 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 description 1
• 210000004880 lymph fluid Anatomy 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 238000010801 machine learning Methods 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 108091005485 macrophage scavenger receptors Proteins 0.000 description 1
• 239000006249 magnetic particle Substances 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 229910052748 manganese Inorganic materials 0.000 description 1
• 239000011572 manganese Substances 0.000 description 1
• 238000013178 mathematical model Methods 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 229940125956 metalloenzyme inhibitor Drugs 0.000 description 1
• 239000003475 metalloproteinase inhibitor Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 108010029942 microperoxidase Proteins 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000003226 mitogen Substances 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 238000011512 multiplexed immunoassay Methods 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 230000009670 mycobacterial growth Effects 0.000 description 1
• 208000027531 mycobacterial infectious disease Diseases 0.000 description 1
• 229920003052 natural elastomer Polymers 0.000 description 1
• 229920001194 natural rubber Polymers 0.000 description 1
• 238000004848 nephelometry Methods 0.000 description 1
• 108010087904 neutravidin Proteins 0.000 description 1
• 210000002445 nipple Anatomy 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 239000000820 nonprescription drug Substances 0.000 description 1
• 108091008104 nucleic acid aptamers Proteins 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 239000000382 optic material Substances 0.000 description 1
• 239000011368 organic material Substances 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 239000012285 osmium tetroxide Substances 0.000 description 1
• 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• QVGXLLKOCUKJST-BJUDXGSMSA-N oxygen-15 atom Chemical compound [15O] QVGXLLKOCUKJST-BJUDXGSMSA-N 0.000 description 1
• 238000005192 partition Methods 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 102000041715 pentraxin family Human genes 0.000 description 1
• 108091075331 pentraxin family Proteins 0.000 description 1
• 239000000863 peptide conjugate Substances 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical group [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Chemical group 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
• OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
• 239000000902 placebo Substances 0.000 description 1
• 229940068196 placebo Drugs 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
• 208000024356 pleural disease Diseases 0.000 description 1
• 210000004910 pleural fluid Anatomy 0.000 description 1
• 231100000614 poison Toxicity 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
• 229920002239 polyacrylonitrile Polymers 0.000 description 1
• 239000004417 polycarbonate Substances 0.000 description 1
• 229920000515 polycarbonate Polymers 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 230000000379 polymerizing effect Effects 0.000 description 1
• 239000004926 polymethyl methacrylate Substances 0.000 description 1
• 239000011116 polymethylpentene Substances 0.000 description 1
• 229920000306 polymethylpentene Polymers 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
• 239000004810 polytetrafluoroethylene Substances 0.000 description 1
• 229920002689 polyvinyl acetate Polymers 0.000 description 1
• 239000011118 polyvinyl acetate Substances 0.000 description 1
• 239000004800 polyvinyl chloride Substances 0.000 description 1
• 229920000915 polyvinyl chloride Polymers 0.000 description 1
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 238000010837 poor prognosis Methods 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000013155 positive regulation of cell migration Effects 0.000 description 1
• 230000035409 positive regulation of cell proliferation Effects 0.000 description 1
• 230000025902 positive regulation of locomotion Effects 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 239000000955 prescription drug Substances 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 239000003805 procoagulant Substances 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 230000002250 progressing effect Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 230000026447 protein localization Effects 0.000 description 1
• 239000012460 protein solution Substances 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 238000000575 proteomic method Methods 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 150000003230 pyrimidines Chemical group 0.000 description 1
• 125000000714 pyrimidinyl group Chemical group 0.000 description 1
• 229940079877 pyrogallol Drugs 0.000 description 1
• 238000005173 quadrupole mass spectroscopy Methods 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• 238000010833 quantitative mass spectrometry Methods 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 239000002516 radical scavenger Substances 0.000 description 1
• 239000000700 radioactive tracer Substances 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• 229910052761 rare earth metal Inorganic materials 0.000 description 1
• 150000002910 rare earth metals Chemical class 0.000 description 1
• 230000035484 reaction time Effects 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 239000003237 recreational drug Substances 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 238000005057 refrigeration Methods 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 230000020964 regulation of blood coagulation Effects 0.000 description 1
• 230000020129 regulation of cell death Effects 0.000 description 1
• 230000015139 regulation of coagulation Effects 0.000 description 1
• 230000012500 regulation of defense response Effects 0.000 description 1
• 230000012121 regulation of immune response Effects 0.000 description 1
• 230000004985 regulation of immune system process Effects 0.000 description 1
• 230000031337 regulation of inflammatory response Effects 0.000 description 1
• 230000009531 regulation of multicellular organismal process Effects 0.000 description 1
• 230000018866 regulation of programmed cell death Effects 0.000 description 1
• 230000020883 regulation of protein transport Effects 0.000 description 1
• 230000012664 regulation of response to stimulus Effects 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000024769 regulation of transport Effects 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 238000004153 renaturation Methods 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 208000023504 respiratory system disease Diseases 0.000 description 1
• 230000012423 response to bacterium Effects 0.000 description 1
• 230000008399 response to wounding Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 229930182490 saponin Natural products 0.000 description 1
• 235000017709 saponins Nutrition 0.000 description 1
• 150000007949 saponins Chemical class 0.000 description 1
• 238000004574 scanning tunneling microscopy Methods 0.000 description 1
• 230000037390 scarring Effects 0.000 description 1
• 108091005418 scavenger receptor class E Proteins 0.000 description 1
• 102000014452 scavenger receptors Human genes 0.000 description 1
• 238000013077 scoring method Methods 0.000 description 1
• 238000007790 scraping Methods 0.000 description 1
• 238000001004 secondary ion mass spectrometry Methods 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 210000000582 semen Anatomy 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 229910000077 silane Inorganic materials 0.000 description 1
• 150000003376 silicon Chemical class 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 238000002922 simulated annealing Methods 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 239000011537 solubilization buffer Substances 0.000 description 1
• 238000002798 spectrophotometry method Methods 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 238000012421 spiking Methods 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000011255 standard chemotherapy Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 238000011301 standard therapy Methods 0.000 description 1
• 238000011272 standard treatment Methods 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 238000004659 sterilization and disinfection Methods 0.000 description 1
• 239000011550 stock solution Substances 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 229920003048 styrene butadiene rubber Polymers 0.000 description 1
• 210000004895 subcellular structure Anatomy 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 238000012706 support-vector machine Methods 0.000 description 1
• 238000010897 surface acoustic wave method Methods 0.000 description 1
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
• 210000001179 synovial fluid Anatomy 0.000 description 1
• 229920002994 synthetic fiber Polymers 0.000 description 1
• 230000033772 system development Effects 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 150000003505 terpenes Chemical class 0.000 description 1
• 235000007586 terpenes Nutrition 0.000 description 1
• BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
• VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 201000005665 thrombophilia Diseases 0.000 description 1
• 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
• 238000001776 time-resolved fluorescence quenching Methods 0.000 description 1
• 230000017423 tissue regeneration Effects 0.000 description 1
• 230000008427 tissue turnover Effects 0.000 description 1
• 239000003440 toxic substance Substances 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 238000004879 turbidimetry Methods 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 230000009452 underexpressoin Effects 0.000 description 1
• 238000012315 univariate regression analysis Methods 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• 235000019168 vitamin K Nutrition 0.000 description 1
• 239000011712 vitamin K Substances 0.000 description 1
• 150000003721 vitamin K derivatives Chemical class 0.000 description 1
• 229940046010 vitamin k Drugs 0.000 description 1
• XLYOFNOQVPJJNP-OUBTZVSYSA-N water-17o Chemical compound [17OH2] XLYOFNOQVPJJNP-OUBTZVSYSA-N 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 208000016261 weight loss Diseases 0.000 description 1
• 230000036642 wellbeing Effects 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 210000002268 wool Anatomy 0.000 description 1
• 230000003936 working memory Effects 0.000 description 1
• 239000012224 working solution Substances 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1